ORIOR – Ausübung Mehrzuteilungs-Option

Not for release, publication or distribution in the United States of America, Canada, Japan or Australia

Zürich, 6. Mai 2010 - Im Zusammenhang mit der erfolgreichen Platzierung von 3’425’000 Namenaktien anlässlich des Initial Public Offerings der ORIOR AG hat die Credit Suisse AG als Global Co-ordinator und Bookrunner im Namen des Bankensyndikats gestern die Mehrzuteilungs-Option von 513’750 Namenaktien vollumfänglich ausgeübt. Einschliesslich der im Rahmen der Mehrzuteilungs-Option zugeteilten Namenaktien wurden insgesamt 3’938’750 Namenaktien der ORIOR platziert, was einem Emissionsvolumen von CHF 189 Millionen entspricht und in einem Free Float von ungefähr 66% resultiert. Die der Mehrzuteilungs-Option zugrunde liegenden 513’750 Namenaktien stammen aus dem Bestand von Capvis. Damit bleibt die Anzahl ausgegebener Aktien unverändert bei 5’925’000 Namenaktien.

Media Relations Credit Suisse AG, Telefon +41 844 33 88 44, media.relations@credit-suisse.com

Credit Suisse AG

Credit Suisse AG Die Credit Suisse AG ist einer der weltweit führenden Finanzdienstleister und gehört zur Unternehmensgruppe der Credit Suisse (nachfolgend «die Credit Suisse»). Als integrierte Bank bietet die Credit Suisse ihren Kunden ihr gebündeltes Fachwissen in den Bereichen Private Banking, Investment Banking und Asset Management an. Sie offeriert Unternehmen, institutionellen Kunden und vermögenden Privatkunden weltweit sowie Retailkunden in der Schweiz fachspezifische Beratung, umfassende Lösungen und innovative Produkte. Die Credit Suisse mit Hauptsitz in Zürich ist in über 50 Ländern tätig und beschäftigt etwa 48 300 Mitarbeitende. Die Namenaktien (CSGN) der Credit Suisse Group AG, der Muttergesellschaft der Credit Suisse, sind in der Schweiz sowie, in Form von American Depositary Shares (CS), in New York kotiert. Weitere Informationen über die Credit Suisse finden Sie unter www.creditsuisse.com


This document does neither constitute an offer to buy or to subscribe to shares of ORIOR AG nor a prospectus within the meaning of the applicable Swiss law. Investors should make their decision to buy or to subscribe to shares solely based on the official offering and listing prospectus. Investors are furthermore advised to consult their bank or financial adviser. This publication may contain specific forwardlooking statements, e.g. statements including terms like “believe”, “assume”, “expect” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not rely on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. This document is not being issued in the United States of America and should not be distributed or otherwise transmitted in the United States or to U.S. persons (as defined in the U.S. Securities Act of 1933, as amended (the “Securities Act”)) or publications with a general circulation in the United States. This document does not constitute an offer or invitation to subscribe for or purchase any securities. The securities of ORIOR AG have not been and will not be registered under the Securities Act and are not being offered or sold in the United States or to U.S. persons. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom. This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive. This document does not constitute a prospectus pursuant to art. 652a and/or 1156 of the Swiss Code of Obligations or art. 27 et seqq. of the listing rules of the SIX Swiss Exchange. A decision to invest in shares of ORIOR AG should be based exclusively on the issue and listing prospectus published by ORIOR AG for such purpose. The securities described herein are offered publicly in Switzerland only. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.